Identification of a Novel Chemokine-related Long Non-coding RNA Risk Model Via Comprehensive Prognostic and Immune Analyses in Pancreatic Cancer

Key Points

• To establish a chemokine-related long non-coding RNA risk model and evaluate its prognostic significance in pancreatic cancer.
• Conducted comprehensive analyses of chemokine-related lncRNAs
• Evaluated the prognostic value of the identified model
• Performed immune analyses related to the risk model
• The lncRNA risk model showed significant prognostic value in pancreatic cancer
• Potential implications for developing new therapeutic strategies were identified